Longitudinal Study of Survival and Causes of Death in Patients with Thalassemia Major in Greece

Keywords

Medicine, Thalassemia, Hemosiderosis, Sepsis, Internal medicine

References

• Prolonged survival in patients with beta-thalassemia major treated with deferoxamine.Kathryn H. Ehlers, Patricia J. Giardina, Martin Lesser — 1991
• Survival and Disease Complications in Thalassemia MajorCaterina Borgna‐Pignatti, Simone Rugolotto, Piero De Stefano — 1998
• Survival in β-thalassaemia major in the UK: data from the UK Thalassaemia RegisterBernadette Modell, Maren Khan, Matthew Darlison — 2000
• Molecular characterization of β‐thalassaemia in 174 Greek patients with thalassaemia majorC. Kattamis, Hongbo Hu, George Z. Cheng — 1990
• Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia.John B. Porter, Bradley W. Davis — 2002
• Combined therapy with desferrioxamine and deferiprone in thalassemic patients: effect on urinary iron excretion.Antonis Kattamis, Christina Kassou, Helen Berdousi — 2003
• Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemiaJohn B. Porter — 2002

Cited by

• Current Trends in the Management of Beta ThalassemiaRaffaella De Vita — 2008
• Awareness among parents of children with thalassemia major.Fehmina Arif, Jabeen Fayyaz, Ahmer Hamid — 2008
• Iron-Chelating Therapies in a Transfusion-Dependent Thalassaemia Population in ThailandNantasit Luangasanatip, Nathorn Chaiyakunapruk, Nilawan Upakdee — 2011
• Development and Validation of a Multidimensional Expectation Questionnaire for Thalassaemia Major PatientsIoannis Κoutelekos, Helen Kyritsi, Alexandros Makis — 2015
• Early impairment of myocardial function in young patients with β‐thalassemia majorDamiano Magrì, Susanna Sciomer, Francesco Fedele — 2008
• Relation of chelation regimes to cardiac mortality and morbidity in patients with thalassaemia major: an observational study from a large Greek UnitVassilios Ladis, Giorgos Chouliaras, Vasilios Berdoukas — 2010
• Anemia and Iron ManagementAnatole Besarab — 2011
• Sustained Ventricular Tachycardia in a Patient with Thalassemia MajorNermin Bayar, Şakir Arslan, Zehra Erkal — 2013
• Heart Rate Variability for Early Detection of Iron Overload Cardiomyopathy in β-Thalassemia PatientsNut Koonrungsesomboon, Adisak Tantiworawit, Arintaya Phrommintikul — 2015
• Cardiac magnetic resonance in transfusion dependent thalassaemia: assessment of iron load and relationship to left ventricular ejection fractionGiorgos Chouliaras, Antonis Kattamis, Vasilis Berdoukas — 2010
• Treating thalassemia major-related iron overload: the role of deferiproneVasili Berdoukas, Farmaki, Carson — 2012
• Erythropoiesis-stimulating agents in the treatment of anemia in myelodysplastic syndromes: a meta-analysisVictor Moyo, Patrick Lefèbvre, Mei Sheng Duh — 2008
• Cardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association.Dudley J. Pennell, James E. Udelson, Andrew E. Arai — 2013
• Malignancies in patients with β‐thalassemia major and β‐thalassemia intermedia: A multicenter study in IranMehran Karimi, Rahil Giti, Sezaneh Haghpanah — 2009
• In search of the optimal iron chelation therapy for patients with thalassemia majorVasilios Berdoukas, John C. Wood — 2011
• Pharmacoeconomic Considerations in Treating Iron Overload in Patients with β-Thalassaemia, Sickle Cell Disease and Myelodysplastic Syndromes in the USBin Zhang, Prina Donga, Mitra Corral — 2011
• A national registry of haemoglobinopathies in Greece: Deducted demographics, trends in mortality and affected birthson behalf of the Greek Haemoglobinopathies Study Group, Ersi Voskaridou, Vasilis Ladis — 2012
• Hepatitis B and C Infections in Multitransfused Thalassemic PatientsVed Prakash Choudhry — 2015
• Hepatitis C in patients with β-thalassemia major. A single-centre experienceChristos Triantos, Alexandra Kourakli, Maria Kalafateli — 2013
• Cardiac mortality in β‐thalassemia major: resting but not dobutamine stress echocardiography predicts mortality among initially cardiac disease‐free patients in a prospective 12‐year studyGeorge Hahalis, Alexandra Kourakli, Ιωάννα Γερασιμίδου — 2009

Related papers

• Serum Ferritin a Predictor of Iron Overload in Patients with Thalassemia and Sickle Cell DiseaseZahra Pakbaz, Roland A. Fischer, Richard Gamino — 2004
• [Hemosiderosis in thalassemia major. Quantitative study with magnetic resonance (MR)].Leonardo Rossi, Alessandro Castriota-Scanderbeg, F Ferrozzi — 1992
• Pictorial review Imaging features of thalassemiaGülgün Engin, G. DinÁol, Gülden Acunaş — 1999
• The survival analysis of patients with digestive cancerGuo Hai-qian — 2012
• [Long-term clinical evaluation of different types of resin-bonded fixed partial denture to replace lost anterior teeth].L Y Liu, K Li, Jingwen Yang — 2023
• Survival analysis on stomach cancer of Fuzhou in 1992-1999Ju Tian — 2003
• Survival Analysis After Kassi Operation For Patients With Biliary Atresia.Hongxia Ren — 2005
• Ostrich (Struthio camelus) chick survival to 6 months post hatch : estimation of environmental and genetic parameters and the effect of imprinting, foster parenting and deliberate careMagretha Diane Wang — 2012